Print this page
-
Remote Bimanual Virtual Rehabilitation for Elderly with Cerebral Vascular Disease
Protocol: 042014Principal Investigator:
-
Jasdeep S Hundal
Applicable Disease Sites: Brain and Nervous System -
A Phase 3 Randomized Study of Selumetinib versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma.
Protocol: 111914Principal Investigator:
-
Scott A Moerdler
Applicable Disease Sites: Brain and Nervous System -
A Phase 3 Study of Selumetinib or Selumetinib in Combination with Vinblastine for non-NF1, non-TSC Patients with Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations.
Protocol: 112102Principal Investigator:
-
Richard A Drachtman
Applicable Disease Sites: Brain and Nervous System -
A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor.
Protocol: 112104Principal Investigator:
-
Scott A Moerdler
Applicable Disease Sites: Brain and Nervous System -
A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG).
Protocol: 112203Principal Investigator:
-
Scott A Moerdler
Applicable Disease Sites: Brain and Nervous System -
A Phase 2 Study of Dabrafenib with Trametinib after Local Irradiation in Newly-Diagnosed BRAFV600-Mutant High-Grade Glioma (HGG).
Protocol: 112302Applicable Disease Sites: Brain and Nervous System
-
A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors.
Protocol: 112306Principal Investigator:
-
Peter D. Cole
Applicable Disease Sites: Brain and Nervous System -
Needs Survey for Childhood, Adolescent, Young Adults (CAYA) Cancer Survivors, Their Siblings, and Parents/Caregivers.
Protocol: 132213Principal Investigator:
-
Katie Devine
Applicable Disease Sites: Any Site
Bones and Joints
Brain and Nervous System
Hodgkin's Lymphoma
Leukemia, not otherwise specified
Leukemia, other
Non-Hodgkin's Lymphoma -
Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma.
Protocol: 142202Applicable Disease Sites: Brain and Nervous System
-
NCI - 10505: A Phase 1 and Randomized Phase 2 Trial of Selinexor and Temozolomide in Recurrent Glioblastoma
Protocol: 142301Principal Investigator:
-
Vincent Yeung
Applicable Disease Sites: Brain and Nervous System -
NRG-BN012, A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients with Resectable Brain Metastases
Protocol: 142302Principal Investigator:
-
Nicholas DeNunzio
Applicable Disease Sites: Brain and Nervous System -
Individual Patient Expanded Access for treatment of IDH-1 or IDH2-mutated glioma.
Protocol: 142401Principal Investigator:
-
Vincent Yeung
Applicable Disease Sites: Brain and Nervous System -
Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases.
Protocol: 142403Applicable Disease Sites: Brain and Nervous System